Brest
France
CHU de Brest - Institut de Cancéro-Hématologie
Chronic myelogenous leukaemia, tyrosine kinase inhibitor, interferon, deep molecular response
Direct oral anticoagulants, thrombosis, haemorrhage, atrial fibrillation, myeloproliferative neoplasms